PERBANDINGAN ANTARA MESIN SEMI-OTOMATIS UNTUK UJI KEPEKAAN ANTIBIOTIK KOLISTIN DENGAN BROTH MICRODILUTION SEBAGAI BAKU EMAS
DOI:
https://doi.org/10.31004/jkt.v6i4.34532Keywords:
Antibiotic Susceptibility Test, Broth Microdilution, Colistin, Semi AutomaticAbstract
Kolistin merupakan salah satu antibiotik pilihan terakhir yang efektif melawan infeksi bakteri Gram-negatif yang resisten terhadap semua antibiotik. Uji kepekaan antibiotik kolistin saat ini masih menjadi tantangan, karena tidak ada metode pengujian yang terstandar. Tujuan studi ini adalah membandingkan mesin semi otomatis penguji kepekaan antibiotik kolistin (yang diwakili oleh mesin Vitek®2) dengan broth microdilution (BMD) sebagai baku emas. Metode Penelusuran artikel dilakukan di tiga pangkalan data yaitu Pubmed, Wiley dan Scopus sesuai dengan pertanyaan klinis. Skrining artikel menggunakan kriteria inklusi, mengecek kelengkapan artikel, serta membaca artikel keseluruhan untuk mendapatkan artikel yang sesuai. Artikel dinilai kualitasnya berdasarkan validitas, kepentingan dan aplikabilitas. Hasil dari penelusuran didapatkan lima artikel dari database dan artikel dari google scholar tidak didapatkan artikel yang memenuhi kriteria eligibilitas. Sehingga telaah kritis dilakukan pada kelima artikel tersebut. Hasil telaah pada 3 artikel tersebut adalah Essential agreement (EA) < 90% dan Categorical agreement (CA) > 90%. Artikel lainnya menyebutkan ketidak-konsistenan hasil uji pada isolat E. coli dan K. pneumoniae. Nilai VME didapatkan pada kelima studi dianggap kurang baik pada uji kepekaan menggunakan mesin semi otomatis. Kesimpulan dari penelitian ini ialah pemeriksaan uji kepekaan kolistin dengan metode semi otomatis tidak dapat dijadikan pemeriksaan alternatif uji kepekaan kolistin karena kurang sesuai dengan hasil yang didapatkan dengan metode BMD.References
Carretto, E., Brovarone, F., Russello, G., Nardini, P., El-Bouseary, M. M., Aboklaish, A. F., ... & Tyrrell, J. M. (2018). Clinical validation of SensiTest Colistin, a broth microdilution-based method to evaluate colistin MICs. Journal of Clinical Microbiology, 56(4), 10-1128.
Chand Wattal, Neeraj Goel, Jaswinder Kaur Oberoi, Sanghamitra Datta, Reena Raveendran. (2022). Performance of Three Commercial Assays for Colistin Susceptibility in Clinical Isolates and Mcr-1 Carrying Reference Strain, Indian Journal of Medical Microbiology, 37 (4).
Fahrian. 2023. Antibiotik, Infeksi dan Resistensi. Padang : Andalas University Press.
Giani, T., Arena, F., Vaggelli, G., Conte, V., Chiarelli, A., Henrici De Angelis, L., & Rossolini, G. M. (2015). Colistin-resistant Klebsiella pneumoniae from microbiological surveillance: EDTA-modified Hodge test for phenotypic detection of metalloβ-lactamase production. Diagnostic Microbiology and Infectious Disease, 83(3), 254-258.
Griselda, Z. F. N., & Setiawan, I. (2023). Tinjauan Artikel: Uji Mikrobiologi. Jurnal Farmasi (Journal Of Pharmacy), 12(2), 31-36.
J. Lellouche , D. Schwartz, N. Elmalech, Ben Dalak, E. Temkin, M. Paul, et al. (2019). Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility. Clinical Microbiology and Infection 25, 711-716.
Jayol, A., Poirel, L., Dortet, L., & Nordmann, P. (2016). National Survey of Colistin Resistance among Carbapenemase-Producing Enterobacteriaceae and Acinetobacter baumannii in France. Antimicrobial Agents and Chemotherapy, 60(6), 3856-3860.
Kidd, T. J., Mills, G., Sá-Pessoa, J., Dumigan, A., Frank, C. G., Insua, J. L., Bengoechea, J. A. (2017). A Klebsiella pneumoniae antibiotic resistance mechanism that subdues host defences and promotes virulence. EMBO Molecular Medicine, 9(4), 430-447.
Matuschek, E., Åhman, J., Webster, C., & Kahlmeter, G. (2018). Antimicrobial susceptibility testing of colistin–evaluation of seven commercial MIC products against standard broth microdilution for Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter spp. Clinical Microbiology and Infection, 24(8), 865-870.
N. Pfennigwerth, G. Werner, A. Kaminski, M. Korte-Berwanger, Y. Pfeifer, M. Simon, J. Jantsch, L. Marlinghaus, S.G. Gatermann. (2019). Evaluation of six commercial products for colistin susceptibility testing in Enterobacterales. Clinical Microbiology and Infection 25, 1385-1389.
Qi Zhang, Junhong Xu, Wenjuan Yan, Nan Jinq, Shanmei Wang, Youhua Yuan, Bing Ma, Ying Sun, Yafei Chu, Jiangfeng Zhang, Qiong Ma, Baoya Wang, Wenbo Xu, Liqiang Zhu, Caiqin Shi, Juan Fang, Yi Li, Shengqun Liu. (2023). Evaluation of Commercial Products for Colistin and Polymyxin B Susceptibility Testing for mcr-Positive and Negative Escherichia coli and Klebsiella pneumoniae in China. Infection and Drug Resistance, 16.
Sara L. Asser, Dina Aly Kholeif. (2022). Colistin Susceptibility Testing Methods for Carbapenem Resistant Acinetobacter baumannii, A Comparative Study. Egyptian Journal of Medical Microbiology 31, 63-67.
Surbhi Khurana , Rajesh Malhotra, Purva Mathur. (2020). Evaluation of Vitek®2 performance for colistin susceptibility testing for Gram-negative isolates. JAC Antimicrob Resist.
Surojit Das, Subhanita Roy, Samadrita Roy, Gaurav Goelv, Subir Sinha, Purva Mathur, Kamini Walia, Sanjay Bhattacharya. (2022). Colistin Susceptibility Testing of Gram-Negative Bacilli: Better Performance of Vitek®2 System than E-Test Compared to Broth Microdilution Method as the Gold Standard Test, Indian Journal of Medical Microbiology, 38 (1).
Yusuf, E., van Westreenen, M., Goessens, W., & Croughs, P. (2020). The accuracy of four commercial broth microdilution tests in the determination of the minimum inhibitory concentration of colistin. Annals of Clinical Microbiology and Antimicrobials, 19, 1-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Laela Fitriah, Lili Hasanah, Nadia Maretti, Anis Karuniawati

This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).


